Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease

Published:2018-01-24 Issue:2 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Sartini Alessandro,Gitto Stefano,Bianchini Marcello,Verga Maria Chiara,Di Girolamo Maria,Bertani Angela,Del Buono Mariagrazia,Schepis Filippo,Lei Barbara,De Maria Nicola,Villa Erica^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-017-0124-2.pdf

Reference42 articles.

1. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 6, 1388–1402 (2016).

2. Demir, M., Lang, S. & Steffen, H.-M. Nonalcoholic fatty liver disease - current status and future directions. J. Dig. Dis. 10, 541–557 (2015).

3. Wong, V. W. et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 7, 969–974 (2010).

4. Calzadilla Bertot, L. & Adams, L. A. The natural course of non-alcoholic fatty liver disease. Int J. Mol. Sci. 5, 774 (2016).

5. McPherson, S. et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J. Hepatol. 5, 1148–1155 (2015).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of abnormal liver blood tests in patients with inflammatory bowel disease;Frontline Gastroenterology;2024-09-02

2. Effects of lacidophilin in a mouse model of low-grade colitis and nonalcoholic fatty liver disease;Food Bioscience;2024-08

3. Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities;Intestinal Research;2024-06-05

4. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis;BMJ Open;2024-03

5. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease;European Journal of Internal Medicine;2024-02